Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.751 USD | -1.43% | -3.10% | +2.18% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
Financials (USD)
Sales 2023 * | 112M | Sales 2024 * | 64.46M | Capitalization | 20.29M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 0.18 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.31 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 495 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 89.73% |
1 day | -1.43% | ||
1 week | -3.10% | ||
Current month | +5.92% | ||
1 month | +4.89% | ||
3 months | +23.38% | ||
6 months | -32.34% | ||
Current year | +2.18% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Kantrowitz
FOU | Founder | 44 | 14-04-21 |
Jeffrey Hail
FOU | Founder | 61 | 14-04-21 |
Kent Wilson
FOU | Founder | 51 | 14-04-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kent Wilson
FOU | Founder | 51 | 14-04-21 |
Ian Kantrowitz
FOU | Founder | 44 | 14-04-21 |
Gerry Garcia
CHM | Chairman | 43 | 21-03-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.751 | -1.43% | 26,777 |
24-04-18 | 0.7619 | +0.25% | 63,512 |
24-04-17 | 0.76 | +0.90% | 14,354 |
24-04-16 | 0.7532 | +1.78% | 71,948 |
24-04-15 | 0.74 | -4.52% | 78,622 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.18% | 20.58M | |
+0.77% | 102B | |
-0.45% | 29.9B | |
+8.72% | 21.89B | |
-10.07% | 18.96B | |
-7.58% | 17.55B | |
-1.92% | 14.03B | |
-11.13% | 11.64B | |
-4.42% | 10.34B | |
-8.88% | 10.05B |
- Stock Market
- Equities
- ALPP Stock